中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
2020-03-10
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
2020-02-27
Ascletis’ IND Filing for Its Non-alcoholic Steatohepatitis (NASH) Drug Accepted by NMPA
2020-02-18
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody
2020-01-23
«
1
2
3
浙公网安备 33010802003344号
浙ICP备11050387号-1
